Management guidelines and outcome measures in giant cell arteritis (PMR)

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


Giant cell arteritis (GCA) is a common form of vasculitis that predominantly affects the elderly. Cranial symptoms and elevated inflammatory markers are suggestive of the condition and the diagnosis is usually established by temporal artery biopsy. Corticosteroids are the mainstay of treatment for GCA and prolonged therapy is often necessary. Disease relapses and steroid-related adverse effects, however, are common. Serious complications of the disease may include visual loss, stroke, and aortic involvement with aneurysm formation.

Original languageEnglish (US)
Pages (from-to)S137-S141
JournalClinical and experimental rheumatology
Issue number6 SUPPL. 47
StatePublished - Dec 3 2007


  • Aneursym
  • Corticosteroids
  • Giant cell arteritis
  • Polymyalgia rheumatica headache
  • Vasculitis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Management guidelines and outcome measures in giant cell arteritis (PMR)'. Together they form a unique fingerprint.

Cite this